Showing 2141-2150 of 3039 results for "".
- Iridex Announces MicroPulse Transscleral Laser Therapy Now Accepted in the European Glaucoma Society Guidelineshttps://modernod.com/news/iridex-announces-micropulse-transscleral-laser-therapy-now-accepted-in-the-european-glaucoma-society-guidelines/2478696/Iridex reported that MicroPulse Transscleral Laser Therapy (TLT), which is performed using the Iridex Cyclo G6 Laser System and MicroPulse P3 Delivery Device, has been included in the European Glaucoma Society (EGS) Terminology and Guidelines for Glaucoma. The EGS guidelines represent recommendat
- The Cassini Ambient Now Compatible With the Catalys Precision Laser Systemhttps://modernod.com/news/the-cassini-ambient-now-compatible-with-the-catalys-precision-laser-system/2478642/Cassini Technologies announced that the compatibility between the latest cOS 6.0 software for the Catalys Precision Laser System and the Cassini Ambient is ready for market launch. The Cassini Ambient and Catalys Precision Laser System will be jointly promoted as part of a collaboration agreement
- Focus Vision Supplements Now Offer Eyelid Products to Soothe Dry Eye and Aid in Postoperative Healinghttps://modernod.com/news/focus-vision-supplements-now-offer-eyelid-products-to-soothe-dry-eye-and-aid-in-postoperative-healing/2478622/Covalent Medical, owner of Focus Vision Supplements, has developed two new products to aid in pre/postoperative care and soothe the symptoms of occasional dry eye and blepharitis. Focus Eyelid Scrub Formula is a preservative-free, deep-cleaning foam eyelid cleanser
- New Alcon Innovations in IOLs, Digital Health Solutions to be Showcased at the AAO 2020 Virtual Annual Meetinghttps://modernod.com/news/new-alcon-innovations-in-iols-digital-health-solutions-to-be-showcased-at-the-aao-2020-virtual-annual-meeting/2478506/Alcon will highlight a robust scientific program including new data and advancements across its portfolio of innovations in cataract, refractive and retina surgery during the American Academy of Ophthalmology (AAO) 2020 virtual annual meeting, which takes place November 13-15, 2020, according to
- Orasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for Presbyopiahttps://modernod.com/news/orasis-raises-30-million-to-advance-the-clinical-development-of-novel-treatment-for-presbyopia/2478356/Orasis Pharmaceuticals announced the closing of a $30 million Series C financing. Proceeds from the financing will be used to advance Orasis’ lead eye drop candidate for the treatment of presbyopia sympto
- Alcon Focuses on Presbyopia-Correcting IOL Innovation and the New Normal at the Virtual ESCRS 2020https://modernod.com/news/alcon-focuses-on-presbyopia-correcting-iol-innovation-and-the-new-normal-at-the-virtual-escrs-2020/2478344/Alcon will host several events and present new technologies in cataract surgery during the virtual European Society of Cataract and Refractive Surgery (ESCRS) 2020 annual meeting, taking place October 2-4. “As
- Bausch Health Announces Vyzulta Now Approved in Seven Countries; Expanded Coverage in Canadahttps://modernod.com/news/bausch-health-announces-vyzulta-now-approved-in-seven-countries-expanded-coverage-in-canada/2478323/Bausch Health Companies and Nicox announced that Vyzulta (latanoprostene bunod ophthalmic solution) 0.024% has received regulatory approval in Ukraine, bringing the total number of countries where Vyzulta is approved to market to seven. These countries include
- Study Finds Novel Mechanism That May Confer Protection Against Glaucomahttps://modernod.com/news/study-finds-novel-mechanism-that-may-confer-protection-against-glaucoma/2478298/A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection that promotes resistance to the elevated intraocular pressure associa
- CEO Says Moderna Will Know by November if COVID-19 Vaccine Workshttps://modernod.com/news/ceo-says-moderna-will-know-by-november-if-covid-19-vaccine-works/2478294/
- BVI Expands Malosa Single-Use Instrument Range in the UShttps://modernod.com/news/bvi-expands-malosa-single-use-instrument-range-in-the-us/2478253/BVI announced the extension of its Malosa range of single-use ophthalmic instruments in the US. The US Malosa portfolio will now include specialty instruments for use in corneal refractive surgery, complementing the existing single-use product range for cataract, oculoplastic, and office-based pr